117 related articles for article (PubMed ID: 35537008)
1. New Approaches Promise to Improve Local Ewing Sarcoma Results.
Cohen IJ; Ash S
J Pediatr Hematol Oncol; 2022 Aug; 44(6):280-284. PubMed ID: 35537008
[TBL] [Abstract][Full Text] [Related]
2. SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS.
Cohen IJ; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Feinmesser M; Avigad S; Ash S
Cancer Chemother Pharmacol; 2019 May; 83(5):859-866. PubMed ID: 30770960
[TBL] [Abstract][Full Text] [Related]
3. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Ferrari S; Sundby Hall K; Luksch R; Tienghi A; Wiebe T; Fagioli F; Alvegard TA; Brach Del Prever A; Tamburini A; Alberghini M; Gandola L; Mercuri M; Capanna R; Mapelli S; Prete A; Carli M; Picci P; Barbieri E; Bacci G; Smeland S
Ann Oncol; 2011 May; 22(5):1221-1227. PubMed ID: 21059639
[TBL] [Abstract][Full Text] [Related]
4. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
Hawkins D; Barnett T; Bensinger W; Gooley T; Sanders J
Med Pediatr Oncol; 2000 May; 34(5):328-37. PubMed ID: 10797354
[TBL] [Abstract][Full Text] [Related]
5. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
[TBL] [Abstract][Full Text] [Related]
7. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
[TBL] [Abstract][Full Text] [Related]
9. Post-relapse survival in patients with Ewing sarcoma.
Ferrari S; Luksch R; Hall KS; Fagioli F; Prete A; Tamburini A; Tienghi A; DiGirolamo S; Paioli A; Abate ME; Podda M; Cammelli S; Eriksson M; Brach del Prever A
Pediatr Blood Cancer; 2015 Jun; 62(6):994-9. PubMed ID: 25585917
[TBL] [Abstract][Full Text] [Related]
10. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
[No Abstract] [Full Text] [Related]
11. The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma.
Rasper M; Jabar S; Ranft A; Jürgens H; Amler S; Dirksen U
Pediatr Blood Cancer; 2014 Aug; 61(8):1382-6. PubMed ID: 24729428
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
13. Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.
Drabko K; Raciborska A; Bilska K; Styczynski J; Ussowicz M; Choma M; Wojcik B; Zaucha-Prazmo A; Gorczynska E; Skoczen S; Wozniak W; Chybicka A; Wysocki M; Gozdzik J; Kowalczyk J
Bone Marrow Transplant; 2012 Dec; 47(12):1530-4. PubMed ID: 22609883
[TBL] [Abstract][Full Text] [Related]
14. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG
J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352
[TBL] [Abstract][Full Text] [Related]
15. Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
Laws HJ; van Kaick B; Pape H; Paulussen M; Göbel U
Onkologie; 2003 Dec; 26(6):573-7. PubMed ID: 14709933
[TBL] [Abstract][Full Text] [Related]
16. High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.
McTiernan A; Driver D; Michelagnoli MP; Kilby AM; Whelan JS
Ann Oncol; 2006 Aug; 17(8):1301-5. PubMed ID: 16782749
[TBL] [Abstract][Full Text] [Related]
17. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
18. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing's sarcoma family of tumors.
Iwata S; Yonemoto T; Ishii T; Kumagai K; Imai R; Hagiwara Y; Kamada T; Tatezaki S
Int J Clin Oncol; 2013 Dec; 18(6):1114-8. PubMed ID: 23053401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]